In addition, similar to KRAS c.35G>T (p.Gly12Val), c.34G>T (p.Gly12Cys) has been associated with reduced tumor-infiltrating lymphocytes and an increased tumor–stromal percentage [34]. The gene discussed is KRAS; the disease is neoplasm.